- Q1 2024 scPharmaceuticals Inc Earnings Call TranscriptMay 14, 2024$4.5 (+3.45%)Earnings
- Q4 2023 scPharmaceuticals Inc Earnings Call TranscriptMar 13, 2024$5.44 (+1.49%)Earnings
- Q2 2023 scPharmaceuticals Inc Earnings Call TranscriptAug 10, 2023$7.75 (-1.27%)Earnings
- scPharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- scPharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 06, 2023
- Q1 2023 scPharmaceuticals Inc Earnings Call TranscriptMay 10, 2023$11.36 (+0.80%)Earnings
- Q4 2022 scPharmaceuticals Inc Earnings Call TranscriptMar 22, 2023$6.92 (-0.14%)Earnings
- scPharmaceuticals Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- scPharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- scPharmaceuticals Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Q3 2022 scPharmaceuticals Inc Earnings Call TranscriptNov 09, 2022$5.38 (-4.44%)Earnings
Q1 2024 scPharmaceuticals Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the scPharmaceuticals first-quarter 2024 earnings conference call. (Operator Instructions)
Also note that the call is being recorded Tuesday, May 14, 2024. And I would like to turn the conference over to PJ Kelleher, Investor Relations. Please go ahead.
Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.
All statements on this conference call other than historical facts are forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding scPharmaceuticals, expected future financial results, management's expectations and plans for the business, the ongoing commercialization and marketing of Furoscix and the potential label expansion and other regulatory approval of Furoscix.
The words anticipate, believe, estimate, expect, intend, guidance, confidence, target, project and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)